Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New Invirase 500 mg formulation approved in Europe

May 30, 2005

New anti-HIV agents described in recent patents

May 25, 2005

Tipranavir recommended for accelerated approval by FDA Advisory Committee

May 23, 2005

Favorable pharmacokinetic and therapeutic profile of PL-100 prodrug PPL-100

May 23, 2005

Enrollment begins in phase III study of TMC-114 in HIV

May 20, 2005

Traditional approval for Trizivir

May 18, 2005

SP-01A enters phase II study in treatment-experienced HIV patients

May 13, 2005

HIV-1 immunogen + CpG ODN prevents HIV infection in a novel Trimera mouse model of HIV-1 infection

May 10, 2005

Abbott submits sNDA for more convenient tablet formulation for Kaletra

May 6, 2005

CONRAD receives funding for phase III microbicide trials

May 6, 2005

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...